BOSTON–(BUSINESS WIRE)–20/20 Onsite, a Boston-based eye care company, proudly announces its recent achievement at the Massachusetts Innovation Network 2023 Eddies Awards. The company has been honored with the esteemed Eddies Award in the Healthy Livi…
Author: Business Wire
Inflammasome Therapeutics to Enter Clinic with Treatment for Dry AMD
NEWTON, Mass.–(BUSINESS WIRE)– #NRTIs–Inflammasome Therapeutics (https://inflam.com), a private company, developing a new class of inflammasome inhibitor drugs called Kamuvudines as therapies for prevalent, degenerative diseases, announced the FDA h…
Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)
SAN FRANCISCO–(BUSINESS WIRE)–Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)
National Vision Holdings, Inc. Announces Repurchase of $100 Million of Convertible Notes
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision”) today announced that it has entered into agreements with certain of the holders of its 2.50% Convertible Senior Notes due 2025 (the “2025 Notes”) to repurcha…
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2023 and provides a business update. “We are successfully expanding relationships with …
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported fi…
Donor Alliance Manager Receives Leadership Appointment to National Transplantation Organization
DENVER–(BUSINESS WIRE)–Donor Alliance, the nonprofit organization saving and healing lives through organ and tissue donation and transplantation, is pleased to announce Donor & Family Services Manager Serena Altamirano will be advancing the organ…
Massachusetts Innovation Network Announces 2023 Eddies Winners
BURLINGTON, Mass.–(BUSINESS WIRE)– #innovation–The Massachusetts Innovation Network celebrated the wrap-up of its 2023 Eddies Season last night. The 8-month long innovation-fueling program started in March with nearly 100 startup teams representing …
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quart…
National Vision Holdings, Inc. Reports Third Quarter 2023 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the third quarter ended September 30, 2023. Reade Fahs, National Vision’s CEO, said, “Our third qua…
Real-World Evidence Confirms IDgenetix®-Guided Medication Management Significantly Improves Response and Remission Rates in Patients with Major Depressive Disorder
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CastleBiosciences–Castle announces data demonstrating the impact of IDgenetix® on medication response/remission rates in patients with major depressive disorder (MDD).
Alcon Canada Launches Clareon Vivity, its Latest Advancement in Presbyopia Correcting IOLs
TORONTO–(BUSINESS WIRE)–Alcon Canada Launches Clareon Vivity, its Latest Advancement in Presbyopia Correcting IOLs
Alcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytie
TORONTO–(BUSINESS WIRE)–Alcon, le chef de file mondial des soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui que Clareon VivityMD, la première et la seule lentille intraoculaire (LIO) non diffractive à profond…
Aurion Biotech Named “Regenerative Therapeutics Company Of The Year” By BioTech Breakthrough
SEATTLE & CAMBRIDGE & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced it has been selected as “Regenerative Therapeutics Company of the Year” …
Warby Parker Announces Third Quarter 2023 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2023. “In Q3, we we…
Glaukos Announces Participation in Stifel Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Inotrem Receives Milestone Funding From the Crohn’s & Colitis Foundation IBD Ventures Program to Advance Its Inflammatory Bowel Disease Pipeline
PARIS–(BUSINESS WIRE)– #biotech–Inotrem receives milestone funding from the Crohn’s & Colitis Foundation following the review of its antibody program interim data.
Inotrem reçoit une deuxième tranche de financement de la Crohn’s & Colitis Foundation, via le fonds IBD Ventures, pour son programme dans les maladies inflammatoires chroniques de l’intestin (MICI)
PARIS–(BUSINESS WIRE)–Inotrem, une société de biotechnologie en phase clinique avancée spécialisée dans l’immunothérapie pour les maladies inflammatoires chroniques et aigües, annonce aujourd’hui avoir reçu une deuxième tranche de financement de la C…
Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CSTL–Castle announced data from an exploratory study investigating the potential for developing a test that would complement DecisionDx®-UM.
EyeCare Partners Highlights Clinical and Research Leadership at the American Academy of Ophthalmology (AAO) 2023 in San Francisco
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced key leadership updates and research in ophthalmic innovation, advanced by ECP physicians, at American Academy of Ophtha…